Desmoplakin is Important for Proper Cardiac Cell-Cell Interactions by Bowers, Stephanie L.K. et al.
Desmoplakin is Important for Proper Cardiac Cell-Cell
Interactions
Stephanie L.K. Bowers1, William A. McFadden2, Thomas K. Borg3, and Troy A. Baudino1,4,*
1Department of Medicine, Division of Molecular Cardiology, Texas A&M Health Science Center,
Temple, TX 76504, USA
2Department of Cell and Molecular Physiology, University of North Carolina, Chapel Hill, NC, USA
3Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina,
Charleston, SC 29425, USA
4Central Texas Veterans Health Care System, Temple, TX 76504, USA
Abstract
Normal cardiac function is maintained through dynamic interactions of cardiac cells with each
other and with the extracellular matrix. These interactions are important for remodeling during
cardiac growth and pathophysiological conditions. However, the precise mechanisms of these
interactions remain unclear. In this study we examined the importance of desmoplakin (DSP) in
cardiac cell-cell interactions. Cell-cell communication in the heart requires the formation and
preservation of cell contacts by cell adhesion junctions called desmosome-like structures. A major
protein component of this complex is DSP, which plays a role in linking the cytoskeletal network
to the plasma membrane. Our laboratory previously generated a polyclonal antibody (1611)
against the detergent soluble fraction of cardiac fibroblast plasma membrane. In attempting to
define which proteins 1611 recognizes, we performed two-dimensional electrophoresis and
identified DSP as one of the major proteins recognized by 1611. Immunoprecipitation studies
demonstrated that 1611 was able to directly pulldown DSP. We also demonstrate that 1611 and
anti-DSP antibodies co-localize in whole heart sections. Finally, using a three-dimensional in vitro
cell-cell interaction assay, we demonstrate that 1611 can inhibit cell-cell interactions. These data
indicate that DSP is an important protein for cell-cell interactions and affects a variety of cellular
functions, including cytokine secretion.
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Introduction
The cellular components of the heart are organized into a dynamic, three-dimensional (3D)
network that are involved in chemical, mechanical, and electrical regulation of cardiac
function (Banerjee et al., 2006; Camelliti et al., 2006; Porter & Turner, 2009; Bowers et al.,
2010). Mechanical coupling of these cells occurs through cell-cell junctions. Desmosomes
are organized intercellular junctions of different degrees of complexity that link the
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cytoskeletal network to the plasma membrane at specialized sites of cell-cell interactions
(Farquhar & Palade, 1963; Garrod, 1993; Garrod & Collins, 1994; Cowin & Burke, 1996).
Desmosomes are predominantly found in tissues that undergo mechanical stress, such as the
heart and skin. Disruption of either desmosomes or the intermediate filament (IF) network
can have devastating effects on tissue architecture and integrity (Coulombe & Fuchs, 1994;
Fuchs, 1994; McLean & Lane, 1995; Bierkamp et al., 1996; Ruiz et al., 1996; Norgett et al.,
2000; den Haan et al., 2009). Desmosomes consist of multiple membrane proteins including
desmogleins, desmocollins, and the most abundant desmosomal protein, desmoplakin (DSP)
(O’Keefe et al., 1989; Cowin & Burke, 1996).
It has been shown in mice that genetic deletion of dsp results in embryonic lethality
(Gallicano et al., 1998). These studies demonstrated that DSP is critical in anchoring the IF
network to desmosomes, as well as playing a key role in desmosome assembly (Gallicano et
al., 1998). To better understand the importance of DSP, Gallicano and colleagues performed
tetraploid rescue experiments on dsp-deficient embryos (Gallicano et al., 2001). These
animals survived longer than conventional dsp knockout mice but still died shortly after
gastrulation from defects in heart and skin epithelium (Gallicano et al., 2001). In humans, it
has been shown that mutations in DSP can disrupt IF-DSP interactions (Norgett et al., 2000).
In addition, mutations or loss of DSP have been shown to cause arrhythmogenic left
ventricular cardiomyopathy (Norgett et al., 2000; Norman et al., 2005; Uzumcu et al., 2006).
Moreover, cardiac-specific dsp−/− mouse embryos exhibit growth arrest at E10–E12, have
no circulating red blood cells, and are approximately 50% smaller than heterozygous and
wild-type embryos (Garcia-Gras et al., 2006). Cardiac-specific dsp−/− embryos also
displayed poorly formed hearts with no chamber specification; however, the cardiac
phenotype is normal in wild-type and dsp−/− embryos (Garcia-Gras et al., 2006).
Furthermore, it was demonstrated that the cardiac-specific dsp-deficient mice recapitulated
the phenotype of human arrhythmogenic right ventricular cardiomyopathy by exhibiting
fibroadipocytic replacement of myocytes, increased myocyte apoptosis, ventricular
dysfunction, and ventricular arrhythmias (Garcia-Gras et al., 2006). Finally, several studies
have demonstrated that DSP is required for microvascular tube formation (Valiron et al.,
1996; Zhou et al., 2004).
To better examine cell-cell interactions involving fibro-blasts in the heart, a polyclonal
antibody, termed 1611, was raised against the detergent soluble fraction of the cardiac
fibroblast plasma membrane. We have previously used 1611 antibody to inhibit cell-cell
interactions (between myocytes and cardiac fibroblasts), to alter cytokine secretion in vitro,
and to specifically demark cardiac fibroblasts in whole heart sections in vivo (Banerjee et al.,
2006; Bowers et al., 2010). In the current study, we demonstrate in vivo cell-cell interactions
between various cardiac cells using transmission electron microscopy (TEM). We also
demonstrate that DSP is one of the major proteins recognized by 1611 antibodies, as
determined by two-dimensional (2D) gel electrophoresis, proteomic analyses,
immunoprecipitation (IP) studies, and confocal microscopy. Furthermore, we show that both
1611 antibody and knockdown of DSP can block cell-cell interactions in vitro and alter
cytokine secretion. From these studies we conclude that DSP is an important protein
involved in cardiac cell-cell interactions and communication, and that 1611 is a novel
antibody to further study these dynamic cellular relationships.
Materials and Methods
Cardiac Cell Isolation and Culture
The Institutional Animal Care and Use Committee approved these studies. Myocytes were
isolated from day 3 neonatal rat pups as previously described using collagenase digestion
and Percoll gradient purification (Borg et al., 1997; Sharp et al., 1997; Bullard et al., 2005).
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Briefly, animals were sacrificed according to Institutional Animal Care and Use Committee
guidelines and hearts were minced and subjected to multiple digestions in 0.01%
collagenase (Worthington Biochemical Corp., Lakewood, NJ, USA). Myocytes were
separated from fibroblasts by Percoll (GE Healthcare Biosciences, Piscat-away, NJ,
USA)gradient purification as previously published (Borg et al., 1997; Sharp et al., 1997;
Bullard et al., 2005). Myocytes and fibroblasts were counted using a hemocytometer and
plated on aligned collagen. Collagen was aligned on tissue culture plates as previously
described (Simpson et al., 1994; Baudino et al., 2008). Plates were coated with liquid
collagen (Gibco, Langley, OK, USA) in a tissue culture hood and then angled at
approximately 30° to allow the collagen to flow gently from top to bottom, giving the
collagen an aligned appearance. The myocytes were then plated onto these collagen-coated
dishes to achieve an in vivo–like phenotype and used in cell-cell interaction assays as
described below.
Knockdown of Desmoplakin
Ambion Silencer Select siRNA for DSP was purchased from Applied Biosystems (Foster
City, CA, USA). Control siRNA (nontargeting siRNA) was used as a negative control.
Cardiac fibroblasts were plated onto six well plates and transfected with a final
concentration of 10 nM for the corresponding siRNA using Lipofectamine RNAi MAX
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. Cells were
used 48 h after transfection. The efficiency of DSP knockdown was determined by western
blotting and real-time RT-PCR analysis.
Cell-Cell Interaction Assays
Interactions between cardiac fibroblasts and myocytes, between fibroblasts, and between
fibroblasts and endothelial cells (ECs) were assayed as previously described (Baudino et al.,
2008; Bowers et al., 2010). Briefly, cells were co-cultured; media were collected at 1, 2, 4,
6, and 8 h; and viable cells were counted. Data were analyzed by plotting the number of
unattached cells as a function of time. For studies involving disruption of cell-cell
interactions, we preincubated cells with 50 mg of our 1611 antibody. Cardiac fibroblasts
were preincubated with rabbit IgG or with 1611 antibody for 20 min prior to co-culture with
myocytes, fibroblasts, or ECs (Baudino et al., 2008; Bowers et al., 2010). In addition,
cardiac fibroblasts that had been treated with DSP siRNA were used in these studies as
indicated.
Immunoprecipitation Assays
Total protein was isolated from whole heart, cardiac fibroblasts, or myocytes, and each
protein lysate was subjected to IP and western blot analyses as previously described
(Uzumcu et al., 2006). Briefly, tissue or cells were lysed using lysis buffer (20 mM Tris
HCL pH 8.0, 137 mM NaCl, 10% glycerol, 1% Nonidet P-40, 2 mM EDTA plus protease
inhibitor cocktail [Sigma-Aldrich, St. Louis, MO, USA]) and precleared using normal rabbit
IgG (Cell Signaling Technology, Beverly, MA, USA). 100 mg of precleared lysate was then
incubated with 4 mg of 1611 antibody or 2 mg of anti-DSP antibody at 4° C overnight with
rotation. 20 mL of Protein A/G PLUS-Agarose (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA, USA) was added to the lysate/antibody mix and incubated with rotation at 4° C for 4 h.
Each sample was centrifuged, and the beads were washed three times with cold lysis buffer.
Following the last wash, 25 mL of 1X Laemmli sample buffer was added, the sample was
vortexed, heated at 95° C for 5 min, and then subjected to western blot analyses.
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Protein lysates from neonatal cardiac fibroblasts were isolated, immunoprecipitated with
1611 antibody, and subjected to 2D gel electrophoresis using the Bio-Rad Protean IEF
system (Bio-Rad Laboratories, Hercules, CA, USA). After separation by isoelectric point
(pI), the sample was separated by molecular weight. The gel was silver stained,
photographed, and spots picked for matrix-assisted laser desorption/ionization-mass
spectrometry (MALDIMS). Isolated protein spots were sent out for identification (Prot-
Tech, Inc., Eagleville, PA, USA).
Immunofluorescent Staining and Confocal Microscopy
Whole heart sections were cut, fixed in 4% paraformaldehyde for 20 min at room
temperature, washed in 5% bovine serum albumin (BSA) in PBS, and blocked with 10%
goat serum in 5% BSA for 1 h. Sections were incubated with primary antibodies overnight
at 4° C. Sections were washed with 1% BSA/PBS and incubated for 45 min at 37° C with
secondary antibodies. Sections were washed with 1% BSA/PBS and cover-slipped using
DABCO (Sigma). Dried slides were imaged using a Supercontinuum Confocal Leica TCS
SP5 X microscope (Leica Microsystems, Wetzlar, Germany).
Interleukin-6 ELISA
Media samples were collected from co-cultures of wild-type cardiac fibroblasts and
myocytes or wild-type cardiac fibroblasts and ECs that were untreated or treated with 1611
antibody. Media were also collected from co-cultures of cardiac fibroblasts and myocytes or
cardiac fibroblasts and ECs where DSP was knocked down in the fibroblasts. Culture media
were sampled at the indicated time points to examine IL-6 expression using a rat IL-6
ELISA kit (Thermo Scientific, Waltham, MA, USA)as described by the manufacturer.
Transmission Electron Microscopy
Wild-type adult murine hearts (12 weeks old) were isolated following cervical dislocation,
rinsed in ice-cold PBS, “bread-loafed,” and fixed in 4% glutaraldehyde. Mid-wall sections
were cut into 1–2 mm cubes and prepared for electron microscopy as previously described
(Nakagawa et al., 1997). Samples were examined on a JEOL 200CX TEM (JEOL, Tokyo,
Japan) at 160 kV.
Statistical Analysis
Data obtained from all analyses were measured for significance using Student’s t-test or
ANOVA. Results were considered significant when p ≤ 0.05.
Results
Polyclonal Antibody 1611 Recognizes DSP Specifically in Fibroblasts
Transmission electron microscopy was performed on normal 12 week old mouse hearts to
examine cardiac cell-cell interactions (Figs. 1A–1F). TEM studies demonstrated tight cell-
cell interactions between cardiac fibroblasts and myocytes, ECs and myocytes, and
fibroblasts and ECs (Figs. 1A–1C, respectively). Higher magnification of each image clearly
shows electron dense regions and intermingling of plasma membranes (Figs. 1D–1F). We
next investigated the reciprocal spatial distribution of DSP and cells marked by 1611 in
whole heart sections using confocal microscopy. A whole heart section stained with 1611
antibody demonstrates that 1611 specifically recognizes cardiac fibroblasts (Figs. 2A– 2D).
Higher magnification demonstrates clear cell-cell interactions between myocytes and
fibroblasts. In addition, we demonstrate that 1611 specifically stains fibroblasts, as it
demarks the same population identified using vimentin (Supplementary Fig. 1).
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In heart sections stained with 1611 antibody and anti-DSP antibody, we observed co-
localization of signals (Figs. 2E–2I). While not a complete overlay of expression, these
studies demonstrate that our 1611 antibody recognizes DSP or possibly a protein complex
involving DSP.
Desmoplakin is Recognized by the Polyclonal Antibody 1611
To identify the proteins recognized by our 1611 polyclonal antibody, we first chose to
examine the 2D gel electrophoresis profile of protein lysates from cardiac fibroblasts that
were subjected to IP using our 1611 antibody. 2D gel electrophoresis was performed on the
immunoprecipitated samples, and the gel was silver stained to visualize proteins (Fig. 3).
Figure 3 is a representative 2D gel showing the location of the five distinct protein spots that
were immunoprecipitated by 1611 antibody. To identify the proteins, we picked the spots
and subjected them to MALDIMS analyses, which identified one of the major protein spots
as DSP. The protein spots were identified as containing DSP I, DSP II, plakoglobin,
obscurin, and tropomyosin 2.
To confirm that 1611 antibody did indeed recognize DSP, we performed IP studies on
protein lysates from myocytes, cardiac fibroblasts, or whole heart using our 1611 antibody
or using anti-DSP antibody (Fig. 4). Subsequently, we performed western blot analyses
using either 1611 antibody or anti-DSP antibody (Figs. 4A, 4B). When protein lysates were
immunoprecipitated with 1611 antibody and then western blotted with anti-DSP antibody,
we observed a single protein band in the cardiac fibroblast, while two protein bands were
observed in whole heart samples; however, no bands were observed in the myocyte sample
(Fig. 4A). When the 1611 immunoprecipitated lysates were blotted with 1611 antibody, we
observed multiple bands ranging in size from 60 kDa to over 250 kDa (Fig. 4A). This was
expected because when we performed 2D gel electrophoresis (Fig. 3), we observed multiple
protein spots recognized by 1611 antibody. When protein lysates were immunoprecipitated
with anti-DSP antibody, we were able to detect a single protein band in cardiac fibroblast
and whole heart samples western blotted with 1611 antibody and two distinct protein bands
when anti-DSP antibody was used (Fig. 4B). These data demonstrate that DSP is a key
protein recognized by our 1611 antibody.
Desmoplakin is Important for Cardiac Cell-Cell Interactions
Several studies have unveiled that DSP plays a key role in endothelial cell-cell interactions,
as well as tube formation (Schmelz & Franke, 1993; Schmelz et al., 1994; Gallicano et al.,
2001). Therefore, to better define the nature of these cell contacts, 3D in vitro cell-cell
interaction assays were used to define adhesion between myocytes and fibroblasts,
fibroblasts and fibroblasts, and fibroblasts and ECs (Fig. 5). To examine the role of DSP in
cell-cell interactions, we performed siRNA knockdown of DSP in cardiac fibroblasts. Over a
48-h time period, we were able to knockdown dsp expression by approximately 85%, while
control siRNA showed little effect on dsp expression (Fig. 5A). Control IgG-treated cardiac
fibroblasts attached to myocytes over an 8-h time period, with adhesion being measured at 2,
4, and 8 h; however, attachment of fibroblasts to myocytes was significantly blocked by
addition of 1611 antibody or knockdown of dsp (Fig. 5B). Strong interactions were also
observed between cardiac fibroblasts, and 1611 antibody or dsp loss effectively inhibited
these interactions (Fig. 5C). Furthermore, we observed cell-cell interactions between cardiac
fibroblasts and ECs, but as with the other cardiac cell-cell interactions, treatment with 1611
antibody or dsp knockdown resulted in significant disruption of these interactions (Fig. 5D).
Disruption of Cell-Cell Interactions Affects Cytokine Production
Previous studies have shown that cytokine and growth factor secretion is altered when
myocyte-fibroblast interactions are disrupted (Banerjee et al., 2006; Bowers et al., 2010).
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Therefore, to determine whether the secretion of IL-6 could be altered by blocking cell-cell
interactions, myocytes or ECs were co-cultured with cardiac fibroblasts that had previously
been incubated with control IgG, 1611 antibody, or had dsp expression knocked down. As
previously demonstrated by our laboratory (Banerjee et al., 2006; Bowers et al., 2010), the
addition of 1611 antibody to myocyte-fibroblast co-cultures significantly reduced the
concentration of IL-6 secreted into the media (Fig. 6A). In addition, knockdown of dsp in
cardiac fibroblasts resulted in reduced IL-6 expression in myocyte-fibroblast co-cultures
(Fig. 6A). Finally, similar results were observed in co-cultures of cardiac fibroblasts and
ECs treated with 1611 antibody or having reduced dsp expression (Fig. 6B).
Discussion
The results from the current study demonstrate the importance of cell-cell interactions in the
heart and help to define the key players in these interactions. Cell-cell junctions, especially
desmosomes, display a range of morphology from simple contacts to complex, IF
interactions with numerous proteins. DSP has been considered as a cytoplasmic marker of
epithelial desmosomes and by morphological criteria; ECs do not have desmosomes and do
not express desmosomal components such as desmogleins and desmocollins (Schmelz &
Franke, 1993; Schmelz et al., 1994). In this study, we used an in-house polyclonal antibody
to identify and investigate the function of DSP in cardiac cell-cell interactions. We were able
to demonstrate that our 1611 antibody can detect DSP in cardiac fibroblasts. We also
showed that 1611 antibody recognizes multiple proteins, as demonstrated by 2D gel
electrophoresis and western blot analyses. 1611 may be recognizing multiple individual
proteins, as it is a polyclonal antibody, or it may be recognizing a protein complex. Future
studies will further define the intricacies of these interactions. In addition, we demonstrate
that we can disrupt cell-cell interactions between myocytes and fibroblasts, fibroblast
interactions among themselves, and fibroblasts and EC interactions with our 1611 antibody.
As previously shown by our laboratory, interactions between cardiac fibro-blasts and
myocytes are a necessary component of in vitro cytokine secretion (Banerjee et al., 2006;
Bowers et al., 2010). What is important to note from these previous studies is that disruption
of myocyte-fibroblast interactions through the use of connexin 43 (Cx43) blocking antibody
depleted IL-6 secretion (Bowers et al., 2010). Additional studies by our lab and others have
also demonstrated that reduction or loss of dsp results in reduced Cx43 expression (Hames
et al., 2008; Asimaki et al., 2009 and data not shown), which could be the mechanism
through which DSP is altering cell-cell interactions.
TEM and confocal microscopy demonstrated fibroblast-myocyte, myocyte-EC, and
fibroblast-EC interactions. It is clear from these images that these cells are intimately
associated with each other both in vivo and in vitro, and can communicate with each other as
demonstrated by the changes in IL-6 secretion in our co-culture assays. Since it is beneficial
for cardiac cells to be responsive to different signals, such as chemical, mechanical, and
electrical, diverse avenues of communication are necessary to properly differentiate these
signals. The current study demonstrates that DSP clearly plays a role in integration of these
signals.
Little is known concerning the signaling relationships between cardiac fibroblasts,
myocytes, and ECs in either normal or injured tissues. Our previous studies have
demonstrated that multiple molecules are most likely involved in these cell-cell interactions;
however, these studies are the first to demonstrate that DSP could also be involved. These
data reveal that DSP plays a role in myocyte-fibroblast, fibroblast-fibroblast, and fibroblast-
EC interactions, and it may be a critical player in these interactions during the
developmental process, as well as during cardiac remodeling. However, it is important to
emphasize that the contacts we are observing in the heart, especially the myocyte-fibroblast
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and fibroblast-EC are most likely the simple cell contact type and not the complex.
Furthermore, there may be additional differences in the factors that are involved when
examining homotypic versus heterotypic interactions and future directions will continue to
address these questions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Tight interactions between various cells of the heart. TEM of murine left ventricle
demonstrating cell-cell interactions between (A) myocytes and fibroblasts, (B) myocytes and
ECs, and (C) fibroblasts and ECs. High magnification of inset is shown in panels D, E, and
F. Red arrows indicate regions of tight cell-cell interactions. Scale bars are shown in
individual panels.
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Desmoplakin staining co-localizes with 1611 antibody staining. A–D: Confocal micrograph
of murine left ventricle showing 1611 staining (red) of cardiac fibroblasts, myocytes with
phalloidin (green), and nuclei with DAPI (blue). E–I: Confocal micrograph demonstrating
partial co-localization of 1611 (red) with DSP (white) in the left ventricle of the mouse
heart. The section was also stained with phalloidin (green) and DAPI (blue). Scale bars are
shown in individual panels.
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Two-dimensional electrophoresis profile of cardiac fibro-blast proteins recognized by 1611
antibody. Cardiac fibroblast protein lysates were immunoprecipitated with 1611 antibody
and subjected to 2D gel electrophoresis. Samples were focused on 7 cm IPG strips (pH 3–
10) and separated in 4–20% SDS-PAGE gels. The proteins were visualized with silver stain
and subjected to MALDI-MS analysis. The protein spots were identified as DSP I, DSP II,
plakoglobin, obscurin, and tropomyosin 2 as indicated in the table. N = 5.
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IP analyses demonstrating that 1611 antibody recognizes DSP. A: Protein lysates from
myocytes, cardiac fibroblasts, or whole heart were immunoprecipitated with 1611 antibody
and then subjected to western blot analyses with either 1611 antibody (upper panel) or anti-
DSP antibody (lower panel). B: Protein lysates from myocytes, cardiac fibroblasts, or whole
heart were immunoprecipitated with anti-DSP antibody and then subjected to western blot
analyses with either 1611 antibody (upper panel) or anti-DSP antibody (lower panel). N = 3.
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Knockdown of DSP expression decreases cell-cell interactions between cardiac fibroblasts,
myocytes, and ECs. A: Cardiac fibroblasts were left untreated or transfected with control or
DSP siRNA (10 nM). Either at 24 or 48 h, the cells were collected and examined for DSP
expression. Significant knockdown of DSP was observed at both 24 and 48 h (p < 0.05).
Fibroblasts were collected at 48 h and used in cell-cell interaction assays. The effects of
DSP knockdown or treatment with 1611 antibody were examined on cell-cell interactions
between (B) myocytes and fibroblasts, (C) fibro-blasts and fibroblasts, or (D) ECs and
fibroblasts. 50 μg of 1611 antibody were used in these studies. Cell-cell interactions were
blocked in all three cultures treated with 1611 antibody (p < 0.05). DSP knockdown in
fibroblasts also inhibited cell-cell interactions (p < 0.05). N = 3. * indicates a significant
difference between experimental sample (1611 treated or DSP knockdown cells) and control
cells. # indicates a significant difference between the two experimental groups (1611 treated
versus DSP knockdown cells).
Bowers et al. Page 13














Disruption of cell-cell interactions results in reduced IL-6 expression. Cardiac fibroblasts
were left untreated, treated with 1611 antibody (50 mg), or treated with DSP siRNA (10
nM). Fibroblasts were then co-cultured with either (A) myocytes or (B) ECs, and media
were collected at indicated time points. Disruption of cell-cell interactions with either 1611
antibody (p < 0.05) or with DSP knockdown (p < 0.05)resulted in reduced IL-6 secretion. N
= 3.
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